{"edition":"atlanta","organization":"Georgia Harm Reduction Coalition","organizationId":"org:georgia-harm-reduction-coalition","boundaryVersion":"OMB-23-01-2023-07-21","updated":"2026-09-29","display":{"metric":{"id":"daly-equivalent","years":1,"label":"DALY","priceLabel":"$ / DALY"},"priceUSD":11049453.037037037,"canonicalPriceUSDPerTenEquivalentYears":110494530.37037037,"conversion":"display only; QALYs and income equivalents are not measured clinical DALYs"},"listDisplay":{"metric":{"id":"daly-equivalent","years":1,"label":"DALY","priceLabel":"$ / DALY"},"priceUSD":11049453.037037037,"canonicalPriceUSDPerTenEquivalentYears":110494530.37037037,"conversion":"display only; QALYs and income equivalents are not measured clinical DALYs"},"model":{"version":"atlanta-ghrc-alpha-v1","costScope":"Whole FY2024 legal-recipient expenses reconciled to audited expense in Schedule D; no netting of grants, public revenue or nonlocal services. Unrecognized volunteer, partner and downstream medical resources unpriced; not a societal-cost estimate.","geographicAttribution":"g=0.25 is an analyst scenario prior, anchored only by five metro sites and confirmed statewide operation across 150 counties. It is not an observed share, population allocation or county-count ratio. Sensitivity spans 0–100%; only pinned 29-county residents count locally.","formula":"Q_gross=R*d*a*r*T*s*u*f; Q_all=Q_gross-H; Q_metro=Q_gross*g-H; H is a metro harm and is included once in both net population totals; price_per_10=10*C/Q_metro only if Q_metro>0","counterfactual":"r accounts for survival through alternative rescue/spontaneous recovery; f accounts for substitution or no service response to an additional unrestricted gift. No lifetime survival extrapolation.","attribution":"a discounts joint GHRC/DBHDD/GOP/NEXT outcomes; d discounts repeat-event overlap. Four partners do not establish equal causal credit: a=0.25 is judgment, not division as an attribution estimator.","uncertainty":"Weak confidence. Every bridge beyond the reported reversal count and legal-recipient cost is judgmental. Scenarios are conditional, not probability-weighted expected values or confidence intervals. Zero benefit remains plausible.","nativeOutcomes":"4,000 reported Narcan reversal events in the 2024 collaborative statewide report; not independently verified unique people or prevented deaths. 32,000 Narcan units are distribution outputs, not rescues.","inputs":[{"name":"C: annual recipient costs","value":9322976,"unit":"USD","basis":"observed","rationale":"Observed in original return and Schedule D; annual-report discrepancy tested separately.","sourceIds":["return24","d24"]},{"name":"R: reported reversal events","value":4000,"unit":"events","basis":"observed","rationale":"Observed as a claim in original annual report, not independently verified; joint effort, no reporting uplift.","sourceIds":["annual24"]},{"name":"d: effective unique-benefit fraction","value":0.5,"unit":"fraction","basis":"judgment","rationale":"Avoid full independent one-year credit for repeated rescues of the same person; actual recurrence unknown.","sourceIds":[]},{"name":"a: GHRC causal contribution","value":0.25,"unit":"fraction","basis":"judgment","rationale":"Joint delivery includes three named partners; equal names do not imply equal causal contributions.","sourceIds":["annual24"]},{"name":"r: incremental survival rescue fraction","value":0.05,"unit":"fraction","basis":"judgment","rationale":"Allows alternative EMS/naloxone/rescue breathing and nonfatal events; study supports mechanism, not this prior.","sourceIds":["walley"]},{"name":"T: finite follow-up","value":1,"unit":"year","basis":"judgment","rationale":"No benefit beyond one year; no lifetime extrapolation.","sourceIds":[]},{"name":"s: survival-area factor","value":0.9,"unit":"fraction","basis":"judgment","rationale":"Competing mortality remains substantial; primary cohort's 5.5% annual mortality is contextual, not direct calibration.","sourceIds":["survival"]},{"name":"u: utility while alive","value":0.6,"unit":"QALY/year","basis":"judgment","rationale":"Illustrative health utility for survival; no local preference-based measurement.","sourceIds":[]},{"name":"f: funding response","value":0.25,"unit":"fraction","basis":"judgment","rationale":"Unverified additional unrestricted gift effect; includes funding substitution.","sourceIds":[]},{"name":"g: Atlanta-metro share","value":0.25,"unit":"fraction","basis":"judgment","rationale":"Five metro sites plus statewide services establish plausibility only, not volume; tested 0–1.","sourceIds":["programs","annual24"]},{"name":"H: net other adverse health","value":0,"unit":"metro QALYs","basis":"judgment","rationale":"Central convention only, not proof of no harm.","sourceIds":[]},{"name":"Verified additional gift capacity","value":null,"unit":"services/USD","basis":"unknown","rationale":"No current quantified funding gap or gift-created service response verified.","sourceIds":["donate"]}],"scenarios":[{"id":"central","label":"Conditional alpha central; donor HOLD","costUSD":9322976,"allPopulationQalys":3.375,"editionQalys":0.84375,"assumptions":"4000*d .5*a .25*r .05*T 1*s .9*u .6*f .25; metro g .25; H 0. All bridge factors judgmental."},{"id":"low","label":"Weak pathway combination","costUSD":9322976,"allPopulationQalys":0.02,"editionQalys":0.001,"assumptions":"R4000,d .25,a .1,r .01,T .5,s .8,u .5,f .1,g .05,H0. Not a confidence bound."},{"id":"high","label":"Favorable pathway combination","costUSD":9322976,"allPopulationQalys":105,"editionQalys":78.75,"assumptions":"R4000,d .75,a .5,r .2,T1,s1,u .7,f .5,g .75,H0. Not a confidence bound."},{"id":"null","label":"No incremental gift benefit","costUSD":9322976,"allPopulationQalys":0,"editionQalys":0,"assumptions":"f=0; similarly r=0 or a=0 removes positive benefit."},{"id":"adverse","label":"Net adverse health stress test","costUSD":9322976,"allPopulationQalys":-1,"editionQalys":-1,"assumptions":"f=0,H=1 metro QALY. Hypothetical stress test, not observed harm."},{"id":"no-metro","label":"Zero metro rescue share","costUSD":9322976,"allPopulationQalys":3.375,"editionQalys":0,"assumptions":"Central except g=0; presence of sites does not prove residence of rescued people."},{"id":"all-metro","label":"100% metro share sensitivity","costUSD":9322976,"allPopulationQalys":3.375,"editionQalys":3.375,"assumptions":"Central except g=1; deliberately generous bound, not an observation."},{"id":"annual-report-cost","label":"Alternate published cost total","costUSD":9368880.18,"allPopulationQalys":3.375,"editionQalys":0.84375,"assumptions":"Uses unreconciled annual report page 23 cost-like total; other factors central."}],"sensitivity":["Halving any positive bridge factor doubles the conditional price; zero removes finite price.","Metro share spans 0–100% explicitly; current 25% is not measured.","Repeat-event factor 1 doubles central benefit; no independent person-level deduplication is available.","No health credit for kits, trainings, meals, screenings or clinical care beyond the modeled rescue pathway.","Annual-report cost total increases price by about 0.49%; bridge uncertainty is much larger."],"missingInputs":["Deduplicated reversal dates, people and county of residence","GHRC versus partner causal contribution and external resources","Counterfactual survival without GHRC-delivered naloxone","Local repeat-overdose and one-year survival follow-up","Preference-based utility after rescue","Current unrestricted funding gap and staffed additional capacity","Reconciliation of 6,355 versus 25,000 recipient denominators and annual-report expense discrepancy"]},"sources":[{"id":"annual24","title":"Original 2024 annual report, visually inspected pages 5, 12, 13, 23","publisher":"Georgia Harm Reduction Coalition","url":"https://drive.google.com/file/d/1ffSOvVIq0DW_0ycWq1X64t0LBecxTYXE/view","published":null,"retrieved":"2026-09-29"},{"id":"return24","title":"Original FY2024 Form 990, IRS reconstruction","publisher":"GHRC / IRS","url":"https://projects.propublica.org/nonprofits/full_text/202501629349300235/IRS990","published":null,"retrieved":"2026-09-29"},{"id":"d24","title":"Original FY2024 Schedule D","publisher":"GHRC / IRS","url":"https://projects.propublica.org/nonprofits/full_text/202501629349300235/IRS990ScheduleD","published":null,"retrieved":"2026-09-29"},{"id":"m24","title":"Original FY2024 Schedule M","publisher":"GHRC / IRS","url":"https://projects.propublica.org/nonprofits/full_text/202501629349300235/IRS990ScheduleM","published":null,"retrieved":"2026-09-29"},{"id":"programs","title":"Current programs and five sites","publisher":"GHRC","url":"https://georgiaharmreduction.org/programs-services/","published":null,"retrieved":"2026-09-29"},{"id":"donate","title":"Official page linking Donate Now and annual reports","publisher":"GHRC","url":"https://georgiaharmreduction.org/media/","published":null,"retrieved":"2026-09-29"},{"id":"walley","title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts","publisher":"Walley et al., BMJ","url":"https://www.bmj.com/content/346/bmj.f174","published":"2013-01-31","retrieved":"2026-09-29"},{"id":"survival","title":"One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose","publisher":"Weiner et al., Annals of Emergency Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31229387/","published":null,"retrieved":"2026-09-29"}]}